There is one clinical trial.
Evaluation of novel coronavirus induced severe pneumonia by dental pulp mesenchymal stem cells
Description: Kaplan-meier method was used to calculate the median glassy shadow time in all subjectsMeasure: Disppear time of ground-glass shadow in the lungs Time: 14 days
Description: Kaplan-meier method was used to calculate the median lung shadow absorption of all subjects on 7, 14, 28, and 360 daysMeasure: Absorption of Lung shadow absorption by CT Scan-Chest Time: 7, 14, 28 and 360 days
Description: T test was used to compare the blood oxygen values of each subject at day 3, 7 and 14Measure: Changes of blood oxygen Time: 3, 7 and 14 days
Data processed on January 01, 2021.
An HTML report was created for each of the unique drugs, MeSH, and HPO terms associated with COVID-19 clinical trials. Each report contains a list of either the drug, the MeSH terms, or the HPO terms. All of the terms in a category are displayed on the left-hand side of the report to enable easy navigation, and the reports contain a list of correlated drugs, MeSH, and HPO terms. Further, all reports contain the details of the clinical trials in which the term is referenced. Every clinical trial report shows the mapped HPO and MeSH terms, which are also hyperlinked. Related HPO terms, with their associated genes, protein mutations, and SNPs are also referenced in the report.Drug Reports MeSH Reports HPO Reports